Pulmonary Drug Delivery Devices Market By Technology (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Copd, Cystic Fibrosis, Diabetes) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025
The report titled “Pulmonary Drug Delivery Devices Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall pulmonary drug delivery devices market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of technology, application, and different geographies. Pulmonary drug delivery devices have been used for decades to deliver drugs for treatment of respiratory diseases. Pulmonary drug delivery pathway is considered as most efficient mode of drug delivery in respiratory diseases because lungs provide a huge surface area of alveoli with vast capillary network which provides an excellent absorbing surface for administration of drugs. Over the decade, rapid onset of action and higher efficiency was observed as the key driving factor for pulmonary delivery systems and also symptomatic relief in treatment of asthma and chronic obstructive pulmonary disease (COPD). Developments in device technology have also led to the development of more proficient delivery systems capable of providing large doses and micro particles into the lung.
For the purpose of this study, the global pulmonary drug delivery devices market is segmented on the basis of technology type into dry powder inhalers, metered dose inhalers, and nebulizers. Furthermore, dry powder inhalers are sub segmented into unit-dose devices and multi-dose devices. Metered dose inhalers are of two types manually actuated pressurized inhalers, and breath actuated pressurized inhaler. Nebulizers comprises jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.
The global pulmonary drug delivery devices market is also segmented on the basis of type of applications such as asthma, COPD, cystic fibrosis, diabetes, and others (allergic rhinitis, tuberculosis, among others). Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.
The geographical segmentation of pulmonary drug delivery devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.
The pulmonary drug delivery devices market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck & Co., Inc., Novartis AG, Omron Corporation and Sunovion Pharmaceuticals Inc. among others.
Based on the type of technology, the global pulmonary drug delivery devices market is segmented as follows:
- Dry Powder Inhalers
- Unit-dose inhalers
- Multi-dose inhalers
- Metered Dose Inhalers
- Manually-actuated pressurized inhaler
- Breath-actuated pressurized inhaler
- Nebulizers
- Jet nebulizers
- Ultrasonic wave nebulizers
- Vibrating mesh nebulizers
In year 2016, metered dose inhalers accounted for the largest market share in pulmonary drug devices market due to key drivers rising prevalence of asthma and COPD across the globe, high patient convenience, the products and technology has penetrated in market over these years, and observed as the most preferred technology by physicians. During the forecast period 2017 – 2025, dry powder inhalers were anticipated as the fastest growing segment due to key driving factors such as short administration and preparation time, fewer irritant effects and control of inhaled dose, and API protection. A few major brands available in dry powder inhalers category are Spiriva, Atrovent, Foradil, Rotahaler, and FlowCaps among others.
Based on the type of application, the global pulmonary drug delivery devices market is segmented as follows:
- Asthma
- COPD
- Cystic fibrosis
- Diabetes
- Others (allergic rhinitis, tuberculosis, among others)
In year 2016, Asthma was observed as the largest application segment in pulmonary drug delivery devices market due to key driving factors such as user-friendly designed device, most efficient and convenient way of drug delivery in asthma, and rising prevalence of asthma is fueling the overall growth of pulmonary drug delivery devices. Diabetes was observed as the fastest growing segment due to ongoing research and development for pulmonary delivery if insulin, a few product approvals delivering insulin through pulmonary pathway, high patient convenience due to non-invasive drug delivery and rising prevalence of diabetes globally.
For the purpose of this study, the global pulmonary drug delivery devices market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
In base year 2016, North America accounted for the largest market share in year 2016 due to key driving factors such as rising prevalence of asthma and COPD, high public awareness related to early diagnosis and treatment for respiratory disorders, developed healthcare infrastructure, and high accessibility to products with advanced technology. According to Centers for Disease Control and Prevention (CDC), in year 2015 number of adults had asthma were 18.4 million of which 6.2 million were children. During forecast period 2017 – 2025, Asia Pacific was observed as the fastest growing region due to key drivers such as rising prevalence of asthma and COPD, increasing air pollution due to rapid industrial growth, and high public awareness related to respiratory disease diagnosis. According to a report published by United Nations (UN), globally around seven million people a year die prematurely due to indoor and outdoor pollution with about 70 per cent of those deaths in the Asia Pacific.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Pulmonary Drug Delivery Devices Market Portraiture
2.1.1. Global Pulmonary Drug Delivery Devices Market, by Technology, 2016
2.1.2. Global Pulmonary Drug Delivery Devices Market, by Application, 2016
2.1.3. Global Pulmonary Drug Delivery Devices Market, by Geography, 2016
Chapter 3. Pulmonary Drug Delivery Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Respiratory Diseases: Epidemiology
3.3. Brand Analysis & Comparison: Pulmonary Drug Delivery Devices
3.4. Pipeline Introduction: Pulmonary Drug Delivery Devices
3.5. Drivers
3.6. Challenges
3.7. Opportunities
3.8. Porter’s Five Forces Analysis
3.9. Attractive Investment Proposition, by Geography
3.10. Major Agreements, Partnerships and Collaborations
3.11. Competitive Landscape
3.11.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Technology
4.3. Dry Powder Inhalers
4.3.1. Single-dose inhalers
4.3.2. Multi-dose inhalers
4.4. Metered Dose Inhalers
4.4.1. Manually-actuated pressurized inhaler
4.4.2. Breath-actuated pressurized inhaler
4.5. Nebulizers
4.5.1. Jet nebulizers
4.5.2. Ultrasonic wave nebulizers
4.5.3. Vibrating mesh nebulizers
Chapter 5. Global Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Application
5.2. Asthma
5.3. COPD
5.4. Cystic fibrosis
5.5. Diabetes
5.6. Others (allergic rhinitis, tuberculosis, among others)
Chapter 6. Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.2.1. North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.2.2. North America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.3.1. Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.3.2. Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Spain
6.3.3.5. Italy
6.3.3.6. Rest of Europe
6.4. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.5.1. Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Pulmonary Drug Delivery Devices Market Analysis, 2015 – 2025
6.6.1. MEA Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
6.6.2. MEA Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA Pulmonary Drug Delivery Devices Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. UAE
6.6.3.2. Saudi Arabia
6.6.3.3. South Africa
6.6.3.4. Rest of MEA
Chapter 7. Company Profiles
7.1. Boehringer Ingelheim GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Novartis AG
7.3. GlaxoSmithKline plc
7.4. AstraZeneca plc
7.5. Teva Pharmaceutical Industries Ltd.
7.6. Merck & Co., Inc.
7.7. MannKind Corporation
7.8. F. Hoffmann-La Roche Ltd.
7.9. Bristol-Myers Squibb Company
7.10. Mylan N.V.
7.11. Omron Corporation
7.12. 3M Healthcare
7.13. Sunovion Pharmaceuticals, Inc.
7.14. Koninklijke Philips N.V.
7.15. Gerresheimer AG
7.16. Bespak
7.17. AptarGroup, Inc.
7.18. SHL Group
7.19. Nypro Healthcare Inc.
7.20. Chiesi Farmaceutici S.p.A.
7.21. Hovione
TABLE 1 Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 2 Global Dry Powder Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Metered Dose Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global Nebulizers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 Global Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 North America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 22 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 AstraZeneca plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 MannKind Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Mylan N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Omron Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 3M Healthcare : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Sunovion Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Koninklijke Philips N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Gerresheimer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Bespak: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 AptarGroup, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 SHL Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Nypro Healthcare Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 Chiesi Farmaceutici S.p.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 42 Hovione: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 Pulmonary Drug Delivery Devices: Market Segmentation
FIG. 2 Global Pulmonary Drug Delivery Devices Market Share, by Technology, 2016 (Value %)
FIG. 3 Global Pulmonary Drug Delivery Devices Market, by Application, 2016 (US$ Mn)
FIG. 4 Global Pulmonary Drug Delivery Devices Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Unit-Dose Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Multi-Dose Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Manually-Actuated Pressurized Inhaler Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Breath-Actuated Pressurized Inhaler Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Jet Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Ultrasonic Wave Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Vibrating Mesh Nebulizers Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Asthma Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 15 Global COPD Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 16 Global Cystic Fibrosis Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 17 Global Diabetes Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 18 Global Other Diseases Treatment Market for Pulmonary Drug Delivery Devices, 2015 – 2025 (US$ Mn)
FIG. 19 U.S. Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 20 Canada Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 21 U.K. Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 22 Germany Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 23 France Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 24 Spain Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 25 Italy Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
FIG. 26 Rest of Europe Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 27 Japan Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 28 China Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 29 India Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 30 Rest of Asia Pacific Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 31 Brazil Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 32 Mexico Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 33 Rest of Latin America Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 34 UAE Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 35 Saudi Arabia Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 36 South Africa Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Market, 2015 – 2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)